Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment.
Takeshi JokoYoshimi NagaiRyusaburo MoriKoji TanakaYuji OshimaYusuke HikichiTetsushi KomoriJoao CarrascoMartine C MaculaitisOliver WillKathleen BeusterienKanji TakahashiPublished in: Patient preference and adherence (2020)
Informing patients with wAMD about the likelihood of long-term VA maintenance when selecting treatment may increase the acceptance of an optimal treatment regimen and number of injections.